DAVID GRANOVSKY

Posts Tagged ‘Reuters’

Faulty French Fake Boob Boss Freed

In ALL ARTICLES on January 27, 2012 at 11:13 am
An undated police mugshot photo shows Jean-Claude Mas, the founder of the French Poly Implant Prothese (PIP) company, displayed on the ''red notice'' posted by Interpol on its website. REUTERS/InterpolFrench implant boss released, faces bodily harm charge
MARSEILLE, France (Reuters) – Jean-Claude Mas, the Frenchman who sparked a global health scare by selling substandard breast implants, was released from police custody on Friday and faces a charge of causing bodily harm, his lawyer said. | Full Article
China cadmium spill threatens drinking water for millions
January 27, 2012 04:45 AM ET
BEIJING (Reuters) – A cancer-causing cadmium discharge from a mining company has polluted a long stretch of two rivers in southern China, and officials warned some 3.7 million people of Liuzhou in the Guangxi region to avoid drinking water from the river, state media reported on Friday. | Full Article
Rivals see no need to match Roche’s big gene bet
January 27, 2012 09:08 AM ET
DAVOS, Switzerland (Reuters) – Roche Holding AG’s rivals Sanofi SA and Novartis AG see no need to match the Swiss drug maker in buying a gene-decoding business like Illumina Inc and reckon they can do partnerships instead. | Full Article
Bill Gates injects $750 million into troubled AIDS fund
January 26, 2012 03:31 PM ET
DAVOS, Switzerland (Reuters) – Microsoft chairman and philanthropist Bill Gates pledged a further $750 million to the troubled global AIDS fund on Thursday and urged governments to continue their support to save lives. | Full Article
James Murdoch to quit GSK board
January 27, 2012 07:56 AM ET
LONDON (Reuters) – News Corp executive James Murdoch, under pressure from a phone-hacking scandal at the News of the World tabloid, is to quit the board of drug maker GlaxoSmithKline to spend more time on his media roles. | Full Article

French implant boss released, faces bodily harm charge.

Higher bleeding risk seen in J&J, Bayer clot drug – Reuters Health Report

In OFF THE BEATEN PATH on April 5, 2011 at 9:43 pm
Higher bleeding risk seen in J&J, Bayer clot drug
April 05, 2011 09:35 AM ET
NEW ORLEANS (Reuters) – A blood clot preventer from Johnson & Johnson and Bayer caused a surprisingly high rate of bleeding in a trial of patients with acute illnesses, representing a significant setback for the drugmakers. | Full Article

https://i0.wp.com/boogey.me/wp-content/themes/mixedmediared/images/DrippingBlood.png

Gmail – Reuters Health Report – dsgrano@gmail.com.

BrainStorm Reschedule Webcast Audio Conference

In BUSINESS OF STEM CELLS on October 15, 2009 at 12:27 pm

NEW YORK & PETACH TIKVAH, Israel–(Business Wire)– BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI – News) , announced today that it will reschedule the webcast audio conference to update shareholders on its strategy and report on the way forward towards clinical trials. This event will be rescheduled for a later date to be announced soon. We apologize for any inconvenience.

via BrainStorm Announces That It Will Reschedule Its Webcast Audio Conference | Reuters.

http://www.clipartheaven.com/clipart/business_&_office/cartoons_(a_-_c)/brainstorm.gif

Advanced Cell Technology Announces Proxy Results | Reuters

In BUSINESS OF STEM CELLS on September 16, 2009 at 2:33 pm

WORCESTER, Mass.–(Business Wire)– Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) announced today that shareholders have approved each proposal in the Company`s proxy statement dated August 5, 2009.

As a result, the 2005 Stock Incentive Plan has been amended to increase the total number of shares available for issuance and the certificate of incorporation has been amended to increase the authorized shares eligible for issuance by the Company.

“We are pleased that shareholders have elected to approve each of the proposals in the proxy, supporting the Company`s efforts to further develop its stem cell technology platform,” said William M. Caldwell IV, the Company`s Chairman and Chief Executive Officer.

“We remain focused on submitting an IND for the RPE program to the FDA for approval to commence a Phase I Clinical Trial prior to the end of the year.”

via Advanced Cell Technology Announces Proxy Results | Reuters.

Are you or a loved one interested in receiving stem cell treatment? For free treatment information, please fill out our treatment form or email don@repairstemcells.org and just put Therapy in the subject box.

Researchers find prostate cancer stem cell – Reuters

In ALL ARTICLES, STEM CELLS IN THE NEWS on September 10, 2009 at 12:48 am

Researchers find prostate cancer stem cell

A prostatic cancer cell in an undated microscopic image.[Agencies]

WASHINGTON (Reuters) – Researchers have found a stem cell, a kind of master cell, that may cause at least some types of prostate cancer.

Their findings are only experimental — the stem cells were found in mice — but could explain at least some types of prostate cancer and eventually offer new ways to treat it, they reported on Wednesday in the journal Nature.

The findings also show a potential new source for prostate tumors — so-called luminal cells, which secrete various compounds used in the prostate.

via Researchers find prostate cancer stem cell | Science | Reuters.

other sources:

New Type Of Adult Stem Cells Found In Prostate May Be Involved In Science

Stem cell firm plans Russia’s 1st post-crisis IPO | Stocks | Reuters

In BUSINESS OF STEM CELLS on August 25, 2009 at 9:44 pm

MOSCOW (Reuters) – Russia’s Stem Cell Institute is seeking to attract some 150 million roubles ($4.75 million) from investors in what would be the country’s first initial public offering in more than a year, the firm’s head said on Tuesday.

The news comes as Russia’s economy is showing early signs of starting to recovering from recession while some of its larger companies again begin to attract funding on domestic and international markets.

The Stem Cell Institute, which has been valued at 500 million roubles, plans to place 25 percent of its capital in mid-November on the innovation and developing companies sector of Russia’s MICEX exchange.

via Stem cell firm plans Russia’s 1st post-crisis IPO | Stocks | Reuters.

Britt’s fight against multiple sclerosis hits home for UNCW | StarNewsOnline.com | Star-News | Wilmington, NC

In ALL ARTICLES, CELEBRITIES & STEM CELLS, STEM CELLS IN THE NEWS on April 15, 2009 at 9:00 pm

ms-pic1

Britt’s fight against multiple sclerosis hits home for UNCW

Published: Wednesday, April 15, 2009 at 5:38 p.m.

Last Modified: Wednesday, April 15, 2009 at 5:38 p.m.

Bryan Britt is foremost on the minds of us who know him. We remember his prodigious home runs, first at Laney High School and later at UNC-Wilmington, where he holds both the career and single season records.

It is also why we also are saddened as he suffers from multiple sclerosis, which erodes the immune system and is considered irreversible.

From a special that aired on Today on NBC, Britt learned of an experimental treatment for MS, using bone marrow for a stem cell transplant to reset the immune system. Treatment also involves chemotherapy.

According to a Reuters story, 81 percent of patients in the early studies exhibited improvement.

According to the Reuters story, another study of 17 patients in Ottawa, Ontario, Canada, also with MS in the aggressive stage, showed signs of remission two years following transplants.

via Britt’s fight against multiple sclerosis hits home for UNCW | StarNewsOnline.com | Star-News | Wilmington, NC.

The Great Beyond: Blood farm to satiate vampires, accountant

In ALL ARTICLES on March 21, 2009 at 8:03 pm

Blood farm to satiate vampires, accountant – August 20, 2008

Scientists say they’ve worked out how to make blood by the gallon, and maybe just in time to save their company.

The development “promises to provide an almost limitless supply suitable for transfusion into any patient” say the Times, which “would also eliminate the risk of transmitting the pathogens that cause hepatitis, HIV and Creutzfeldt-Jakob disease (CJD) through transfusions”. This means that “blood donations and vampire bites may one day be a thing of the past” according to one blogger.

Blood has published the paper as an advance online publication, and according to the abstract Shi-Jiang Lu, of Advanced Cell Technology, and colleagues show that it is feasible that embryonic stem cells can be used to create functional oxygen carrying red blood cells at high yields (1010 to1011 red blood cells per six-well plate of embryonic stem cells). They are not the first group to create red blood cells this way, but they are the first to do it on this scale.

Medical News Today highlighted that “stem-cell originated red blood cells were more like fetal and embryonic blood cells than adult cells, they did show some adult cell characteristics after maturing in vitro.” Similarly, the American Red Cross told Scientific American that while the work is “pioneering,” the technique “has not progressed to the stage where the cultured cells are fully equivalent “to real red blood cells”. This is just one of the issues to sort out before this blood can be used for transfusions.

Susan Shurin, from the National Heart, Lung and Blood Institute in Bethesda, Maryland, also explained to Scientific American that there are sugars on the surface of the cells and if the immune system sees them as risky, it could kill the cells. But she called the new work an “important first step”.

The researchers are now trying to make blood cells using reprogrammed adult cells, called induced pluripotent stem cells, while according to Reuters Advanced Cell Technology, which is one of a few commercial ventures trying to make a business out of the emerging stem cell field, “is desperately seeking investors to keep it afloat”.

“The team at Massachusetts-based Advanced Cell Technology hopes the finding might help save the struggling company,” says the wire service.

via The Great Beyond: Blood farm to satiate vampires, accountant.

%d bloggers like this: